2024 Advisory Board

Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board.
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.

Advisory Board

Heidi Adler

Director, Intellectual Property Rights
Orion Corporation

Brigitte Carion-Taravella

Principal Patent Counsel, Lead Biologics IP EU Global IP Department, Legal, Ethics & business Integrity
Sanofi

Monika Dorda

SVP & General Counsel Global Pharmaceuticals
GSK

Holger J. Dulat

VP IP
Affimed

Sabrina Duschner

VP Patent Litigation Strategy
Fresenius Kabi

Julia Pike

Global IP Head
Sandoz

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Karin Pramberger

Head of IP
Swiss Pharma International AG

Laura Reynolds

Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals

Jiri Slavik

Director, IP
Adalvo

Shohta Ueno

Senior Director, Assistant General Counsel – Dispute Resolution
Regeneron

Emeritus Members

Dominic Adair

Partner
Bristows LLP (U.K)

Bert Oosting

Partner
Hogan Lovells